Cargando…
Circadian dysfunction in response to in vivo treatment with the mitochondrial toxin 3-nitropropionic acid
Sleep disorders are common in neurodegenerative diseases including Huntington's disease (HD) and develop early in the disease process. Mitochondrial alterations are believed to play a critical role in the pathophysiology of neurodegenerative diseases. In the present study, we evaluated the circ...
Autores principales: | Kudo, Takashi, Loh, Dawn H., Tahara, Yu, Truong, Danny, Hernández-Echeagaray, Elizabeth, Colwell, Christopher S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Neurochemistry
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891360/ https://www.ncbi.nlm.nih.gov/pubmed/24328694 http://dx.doi.org/10.1042/AN20130042 |
Ejemplares similares
-
The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and Sleep
por: Loh, Dawn H., et al.
Publicado: (2013) -
Raw data of the effects of Chlorogenic acid in 3-Nitropropionic acid induced toxicity and genotoxicity
por: Norberto, Alarcón-Herrera, et al.
Publicado: (2017) -
Uncoupling oxidative/energy metabolism with low sub chronic doses of 3-nitropropionic acid or iodoacetate in vivo produces striatal cell damage
por: Rodríguez, E, et al.
Publicado: (2010) -
Spatiotemporal expression of osteopontin in the striatum of rats subjected to the mitochondrial toxin 3-nitropropionic acid correlates with microcalcification
por: Riew, Tae-Ryong, et al.
Publicado: (2017) -
Neuroprotective potential of escitalopram against behavioral, mitochondrial and oxidative dysfunction induced by 3-nitropropionic acid
por: Shetty, Shruthi, et al.
Publicado: (2015)